Free Trial
→ Buffett, Gates and Bezos Dumping Stocks (From Banyan Hill Publishing) (Ad)tc pixel
Nathan Rice

Nathan Rice Analyst Performance

Managing Director, Healthcare at Piper Sandler

Nathan Rice is a stock analyst at Piper Sandler in the finance sector, covering 23 publicly traded companies. Over the past year, Nathan Rice has issued 7 stock ratings, including buy and hold recommendations. While full access to Nathan Rice's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Nathan Rice's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Analyst Ranking
Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat
Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
51 Last 8 Years
Buy Recommendations
50.00% 25 Buy Ratings
Companies Covered
23 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy50.0%25 ratings
Hold50.0%25 ratings
Sell0.0%0 ratings

Out of 50 total stock ratings issued by Nathan Rice at Piper Sandler, the majority (50.0%) have been Buy recommendations, followed by 50.0% Hold.

Best & Worst Calls

Exchange Coverage

ExchangePercentageCount
NASDAQ
91.3% of companies on NASDAQ
21 companies
NYSE
8.7% of companies on NYSE
2 companies

Nathan Rice, an analyst at Piper Sandler, currently covers 23 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Finance
23 companies		100.0%

Nathan Rice of Piper Sandler specializes in stock coverage within the Finance sector.

Coverage Industries

IndustryPercentage
BANKS - MIDWEST
13 companies		56.5%
BANKS - NORTHEAST
4 companies		17.4%
STATE COMMERCIAL BANKS
4 companies		17.4%
NATIONAL COMMERCIAL BANKS
2 companies		8.7%

About Nathan Rice

Brandon Rice is a managing director in the Piper Sandler healthcare investment banking group. As a senior member of its medical technology team, he primarily focuses on companies with disruptive technologies. Rice has extensive experience in strategic and capital markets transactions, having executed over 30 M&A deals and more than 80 equity and debt offerings. He is based out of our New York office. Prior to joining Piper Sandler in 2023, Rice spent 17 years at Bank of America Securities, most recently as a managing director in their global healthcare investment banking group. He began his career at Merrill Lynch in 2006, prior to its merger with Bank of America Securities. Rice is a graduate of the Virginia Tech Pamplin College of Business.

Nathan Rice's Ratings History at Piper Sandler

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
Export to Excel
CompanyReport DateActionReport Date Price12-Month
Price Target		Rating12-Month
Price & ROI		Details
Merchants Bancorp stock logo
MBIN
Merchants Bancorp
7/30/2025Reiterated Rating$31.50$41.00Overweight
First Mid Bancshares, Inc. stock logo
FMBH
First Mid Bancshares
7/28/2025Boost Price Target$38.99$49.00Overweight
Bank First National Corporation stock logo
BFC
Bank First National
7/21/2025Boost Price Target$127.58$137.00Neutral
Bank First National Corporation stock logo
BFC
Bank First National
4/17/2025Boost Price Target$107.36$111.00Neutral
Merchants Bancorp stock logo
MBIN
Merchants Bancorp
1/30/2025Boost Price Target$42.35$56.50Overweight
Old Second Bancorp, Inc. stock logo
OSBC
Old Second Bancorp
10/17/2024Set Price Target$17.16$22.50
Bank First National Corporation stock logo
BFC
Bank First National
10/17/2024Boost Price Target$94.07$104.00Neutral
Today's Ratings
Top-Rated Stocks
More Ratings Tools